C
Cochlear
- 2
- Portfolio companies on reccy
- 0
- Hiring now
- 0
- Open roles in the portfolio
- Dec 2025
- Latest portfolio round
Hiring now in the portfolio0
Apply on each company's siteNone of their companies on reccy has an open role right now. Browse all neurotech roles
Portfolio on reccy2
From company funding recordsCompanyRound backedOpen roles
Their companies, round by round
From company funding records- EpiminderMelbourne, Australia
EEG and neural monitoring
- Dec 2025IPO · $125MLed
- Feb 2025Unattributed VC
- Mar 2022Series A · $9MLed
- Mar 2022Bridge
- Mar 2022Early Stage VC · $16M
- Oct 2020Series A · $18M
- NyxoahMont-Saint-Guibert, Belgium
Neuromodulation
- Jun 2026Post-IPO Debt · $15M
- Jun 2026Post-IPO Equity · $95M
- Nov 2025Post-IPO Equity · $25.6MLed
- Nov 2025Post-IPO Debt · $52.3MLed
- Oct 2024Post-IPO Equity · $27M
- Jul 2024Post-IPO Debt · $40.5M
Rounds marked Led list Cochlear as a lead investor; the rest are the company's other funding.
Recent rounds in the portfolio
Portfolio in the news
From the Cortex · last 12 months- Nov 2026
- Nov 2026Resignation of Chief Financial Officer
Epiminder · Epiminder
- Sep 2026Nyxoah Expands Genio as U.S. Sleep Apnea Push Builds
Nyxoah · Articles | Neurofounders
- Jan 2026Epiminder’s US Trial Start Raises Stakes in Drug-Resistant Epilepsy Care
Epiminder · www-middle-news.cdn.ampproject.org
- Dec 2025